P

Inventor

CHU KETING

US14 patents
⚠️ This page may combine multiple inventors who share the name “CHU KETING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS VACCINES & DIAGNOSTIC

5 patents
US7445780B2Nov 4, 2008

Antagonistic anti-CD40 antibodies

NOVARTIS VACCINES & DIAGNOSTIC54 citations94
US7288252B2Oct 30, 2007

Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies

NOVARTIS VACCINES & DIAGNOSTIC32 citations94
US7820170B2Oct 26, 2010

Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies

NOVARTIS VACCINES & DIAGNOSTIC18 citations91
US7611708B2Nov 3, 2009

Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies

NOVARTIS VACCINES & DIAGNOSTIC4 citations72
US7393942B2Jul 1, 2008

Nucleic acids encoding mutant forms of Fas ligand

NOVARTIS VACCINES & DIAGNOSTIC0 citations51

CHIRON CORP

3 patents
US6030834AFeb 29, 2000

Human IKK-beta DNA constructs and cells

CHIRON CORP41 citations94
US6544523B1Apr 8, 2003

Mutant forms of Fas ligand and uses thereof

CHIRON CORP28 citations92
US6077701AJun 20, 2000

Ikkβ regulates transcription factors

CHIRON CORP5 citations72

UNIV CALIFORNIA

2 patents
US5750653AMay 12, 1998

Protein, FAF1, which potentiates Fas-mediated apoptosis and uses thereof

UNIV CALIFORNIA25 citations92
US5962652AOct 5, 1999

Antibodies to protein, FAF1

UNIV CALIFORNIA5 citations74

CHU KETING

2 patents
US8088383B2Jan 3, 2012

Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies

CHU KETING8 citations80
US8058403B2Nov 15, 2011

Antibodies to stromal cell-derived factor-1 polypeptides

CHU KETING0 citations47

SOLIS TERAPEUTICS INC

1 patent
US5738852AApr 14, 1998

Methods of enhancing antigen-specific T cell responses

SOLIS TERAPEUTICS INC112 citations94

FIVE PRIME THERAPEUTICS INC

1 patent
US7776564B2Aug 17, 2010

Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use

FIVE PRIME THERAPEUTICS INC15 citations89